lactic acid has been researched along with salinomycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engberg, RM; Hedemann, MS; Jensen, BB; Leser, TD | 1 |
| Aydın, RS | 1 |
| Cai, G; Chen, H; Ni, M; Xiong, M; Yu, Z; Zeng, Q; Zhang, X | 1 |
| Chen, H; Chen, M; Jiang, J; Sun, C; Tian, S; Yu, C; Zhang, Y | 1 |
| Gümüşderelioğlu, M; Kaynak, G; Tığlı Aydın, RS | 1 |
| Khan, W; Kumar, R; Muntimadugu, E; Rafeeqi, TA; Saladi, S | 1 |
| Daman, Z; Faghihi, H; Montazeri, H | 1 |
| Chen, H; Peng, Q; Sun, J; Zhou, J | 1 |
8 other study(ies) available for lactic acid and salinomycin
| Article | Year |
|---|---|
Effect of zinc bacitracin and salinomycin on intestinal microflora and performance of broilers.
Topics: Amylases; Animals; Anti-Bacterial Agents; Bacitracin; Cecum; Chickens; Clostridium perfringens; Colony Count, Microbial; Digestive System; Duodenum; Female; Gizzard, Avian; Hydrogen-Ion Concentration; Ileum; Jejunum; Lactic Acid; Lactobacillus; Lipase; Male; Pancreas; Pyrans; Rectum | 2000 |
Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Delayed-Action Preparations; Drug Delivery Systems; Female; Humans; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrans; Receptor, ErbB-2; Trastuzumab | 2013 |
Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Aptamers, Nucleotide; Cell Line, Tumor; Glycoproteins; Lactic Acid; Mice; Nanoparticles; Neoplastic Stem Cells; Osteosarcoma; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrans; Rats; Xenograft Model Antitumor Assays | 2015 |
The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles.
Topics: AC133 Antigen; Antigens, CD; Antineoplastic Agents; Aptamers, Nucleotide; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Synergism; ErbB Receptors; Glycoproteins; Humans; Lactic Acid; Liver Neoplasms; Molecular Targeted Therapy; Nanocapsules; Nanoconjugates; Particle Size; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrans; Treatment Outcome | 2015 |
Salinomycin encapsulated nanoparticles as a targeting vehicle for glioblastoma cells.
Topics: Cell Line, Tumor; Delayed-Action Preparations; Glioblastoma; Humans; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polysorbates; Pyrans | 2016 |
CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
Topics: Antibodies; Antineoplastic Agents; Drug Carriers; Drug Compounding; Drug Liberation; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Expression; Humans; Hyaluronan Receptors; Hyaluronic Acid; Lactic Acid; MCF-7 Cells; Molecular Targeted Therapy; Neoplastic Stem Cells; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrans | 2016 |
Salinomycin nanoparticles interfere with tumor cell growth and the tumor microenvironment in an orthotopic model of pancreatic cancer.
Topics: Animals; Apoptosis; beta Catenin; Cadherins; Cell Line, Tumor; Cell Proliferation; Female; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Pancreatic Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrans; Receptors, Transforming Growth Factor beta; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles.
Topics: AC133 Antigen; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Drug Delivery Systems; ErbB Receptors; Humans; Lactic Acid; Lung Neoplasms; Male; Mice; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrans; Xenograft Model Antitumor Assays | 2018 |